TipRanks
Advertisement
Advertisement

IMRX Stock Latest News

3 ‘Strong Buy’ Stocks Under $10 to Watch in October for 100%+ Upside
Market News3 ‘Strong Buy’ Stocks Under $10 to Watch in October for 100%+ Upside
2d ago
NG
CATX
Immuneering presents new data at 2026 AACR on atebimetinib
PremiumThe Fly
Immuneering presents new data at 2026 AACR on atebimetinib
5d ago
IMRX
Atebimetinib’s Weight-Preservation and Survival Benefits in Pancreatic Cancer Underscore Buy Rating and Unchanged $14 Price Target
PremiumRatings
Atebimetinib’s Weight-Preservation and Survival Benefits in Pancreatic Cancer Underscore Buy Rating and Unchanged $14 Price Target
5d ago
IMRX
Immuneering says FDA approval of pancreatic cancer treatment ‘good news’
PremiumThe Fly
Immuneering says FDA approval of pancreatic cancer treatment ‘good news’
1M ago
IMRX
Zillow downgraded, Global Payments upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Zillow downgraded, Global Payments upgraded: Wall Street’s top analyst calls
2M ago
Z
ZG
Immuneering initiated with a Buy at H.C. Wainwright
PremiumThe FlyImmuneering initiated with a Buy at H.C. Wainwright
2M ago
IMRX
Ami Fadia Raises IMRX Price Target to $18 on Strong Phase 3 Progress and Favorable PDAC Treatment Positioning
Premium
Ratings
Ami Fadia Raises IMRX Price Target to $18 on Strong Phase 3 Progress and Favorable PDAC Treatment Positioning
2M ago
IMRX
Immuneering reports Q2 EPS 927c), consensus (27c)
Premium
The Fly
Immuneering reports Q2 EPS 927c), consensus (27c)
2M ago
IMRX
Immuneering publishes preclinical data on atebimetinib in Cancer Research
PremiumThe Fly
Immuneering publishes preclinical data on atebimetinib in Cancer Research
2M ago
IMRX
Immuneering initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Immuneering initiated with an Overweight at Cantor Fitzgerald
3M ago
IMRX
Immuneering Appoints Veteran Biotech Leader as New CFO
PremiumCompany Announcements
Immuneering Appoints Veteran Biotech Leader as New CFO
4M ago
8K
IMRX
Immuneering appoints Andrew Gengos as CFO
PremiumThe Fly
Immuneering appoints Andrew Gengos as CFO
4M ago
IMRX
Immuneering Shareholders Approve Directors and Auditor at Meeting
PremiumCompany AnnouncementsImmuneering Shareholders Approve Directors and Auditor at Meeting
4M ago
8K
IMRX
Immuneering Buy Rating Reaffirmed as Analyst Sees ASCO Sell-Off as Overdone; $11 Price Target Maintained
Premium
Ratings
Immuneering Buy Rating Reaffirmed as Analyst Sees ASCO Sell-Off as Overdone; $11 Price Target Maintained
4M ago
IMRX
Immuneering Advances Atebimetinib With Positive Phase 2a Results
Premium
Company Announcements
Immuneering Advances Atebimetinib With Positive Phase 2a Results
4M ago
8K
IMRX
Midday Fly By: Nvidia unveils new PC chip, Berkshire to buy Taylor Morrison
PremiumThe Fly
Midday Fly By: Nvidia unveils new PC chip, Berkshire to buy Taylor Morrison
4M ago
GM
AMC
Immuneering announces updated clinical data from atebimetinib combination trial
PremiumThe Fly
Immuneering announces updated clinical data from atebimetinib combination trial
4M ago
IMRX
Immuneering reports Q1 EPS (21c), consensus (25c)
PremiumThe Fly
Immuneering reports Q1 EPS (21c), consensus (25c)
5M ago
IMRX
Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors
PremiumCompany Announcements
Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors
5M ago
IMRX
Immuneering announces updated data from Phase 2a trial for atebimetinib
PremiumThe FlyImmuneering announces updated data from Phase 2a trial for atebimetinib
5M ago
IMRX
Immuneering announces presentation of new genetic data at 2026 AACR
Premium
The Fly
Immuneering announces presentation of new genetic data at 2026 AACR
6M ago
IMRX
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/16/2026
Premium
Market News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/16/2026
6M ago
ANGX
IMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >